Literature DB >> 22886346

D-Amino acids in brain neurotransmission and synaptic plasticity.

Jean-Marie Billard1.   

Abstract

Far from our initial view of D-amino acids as being limited to invertebrates, they are now considered active molecules at synapses of mammalian central and peripheral nervous systems, capable of modulating synaptic communication within neuronal networks. In particular, experimental data accumulated in the last few decades show that through the regulation of glutamatergic neurotransmission, D-serine influences the functional plasticity of cerebral circuitry throughout life. In addition, the modulation of NMDA-R-dependent signalling by D-aspartate has been demonstrated by pharmacological studies and after the targeted deletion of the D-aspartate-degrading enzyme. Considering the major contribution of the glutamatergic system to a wide range of neurological disorders such as schizophrenia, Alzheimer's disease and amyotrophic lateral sclerosis, an improved understanding of the mechanisms of D-amino-acid-dependent neuromodulation will certainly offer new insights for the development of relevant strategies to treat these neurological diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22886346     DOI: 10.1007/s00726-012-1346-3

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  30 in total

1.  Neuronal serine racemase associates with Disrupted-In-Schizophrenia-1 and DISC1 agglomerates: Implications for schizophrenia.

Authors:  Ariel A Jacobi; Sarah Halawani; David R Lynch; Hong Lin
Journal:  Neurosci Lett       Date:  2018-11-01       Impact factor: 3.046

Review 2.  Neuropathogenesis of HIV-1-associated neurocognitive disorders: a possible involvement of D-serine.

Authors:  Jianxun Xia; Huangui Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-09-10

Review 3.  Dietary essentiality of "nutritionally non-essential amino acids" for animals and humans.

Authors:  Yongqing Hou; Yulong Yin; Guoyao Wu
Journal:  Exp Biol Med (Maywood)       Date:  2015-06-02

4.  Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.

Authors:  Weiting Tang; Ding Liu; Stephen F Traynelis; Hongjie Yuan
Journal:  Neuropharmacology       Date:  2020-07-24       Impact factor: 5.250

5.  Circuit-specific changes in D-serine-dependent activation of the N-methyl-D-aspartate receptor in the aging hippocampus.

Authors:  M Labarrière; F Thomas; P Dutar; L Pollegioni; H Wolosker; J-M Billard
Journal:  Age (Dordr)       Date:  2014-08-20

Review 6.  D-amino acid-containing supramolecular nanofibers for potential cancer therapeutics.

Authors:  Huaimin Wang; Zhaoqianqi Feng; Bing Xu
Journal:  Adv Drug Deliv Rev       Date:  2016-04-19       Impact factor: 15.470

7.  Identity of the NMDA receptor coagonist is synapse specific and developmentally regulated in the hippocampus.

Authors:  Matildé Le Bail; Magalie Martineau; Silvia Sacchi; Natalia Yatsenko; Inna Radzishevsky; Sandrine Conrod; Karima Ait Ouares; Herman Wolosker; Loredano Pollegioni; Jean-Marie Billard; Jean-Pierre Mothet
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-30       Impact factor: 11.205

8.  D-Amino acid substituted peptides as potential alternatives of homochiral L-configurations.

Authors:  Jianxun Shen
Journal:  Amino Acids       Date:  2021-02-04       Impact factor: 3.520

9.  The gut microbiota affects the social network of honeybees.

Authors:  Joanito Liberti; Tomas Kay; Andrew Quinn; Lucie Kesner; Erik T Frank; Amélie Cabirol; Thomas O Richardson; Philipp Engel; Laurent Keller
Journal:  Nat Ecol Evol       Date:  2022-08-22       Impact factor: 19.100

10.  Global metabolic profiles in a non-human primate model of maternal immune activation: implications for neurodevelopmental disorders.

Authors:  Joseph C Boktor; Mark D Adame; Destanie R Rose; Cynthia M Schumann; Karl D Murray; Melissa D Bauman; Milo Careaga; Sarkis K Mazmanian; Paul Ashwood; Brittany D Needham
Journal:  Mol Psychiatry       Date:  2022-08-26       Impact factor: 13.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.